Published by Benjamin Chiou on 10th October 2024
(Sharecast News) - Shares in Indivior plunged on Thursday after the pharma group cut its full-year revenue forecast for the second times following a weaker-than-expected third-quarter performance from Sublocade, its treatment of moderate to severe opioid use disorder.
URL: http://www.digitallook.com/dl/news/story/34615806/...